Related Experiment Video
Updated: May 24, 2025
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
[Validated clinical prediction model for mortality from COVID-19 in hospitalized patients. What is truly important?]
I Iniesta Hernández1, H Madrona Rodríguez1, O Redondo González2
1Medicina de Familia, Centro de Salud Infante-Juan Manuel, Murcia; Medicina de Familia, Casa de Socorro de Alcalá de Henares, Madrid, España.
Insights
This study developed a COVID-19 prediction model using patient data. The model identifies high-risk patients, aiding clinical decisions and resource management for better COVID-19 outcomes.
Area of Science:
- Clinical Medicine
- Epidemiology
- Biostatistics
Background:
- Hospitalized COVID-19 patients require accurate prognostic tools for effective resource allocation.
- Understanding mortality predictors is crucial for improving patient outcomes.
Purpose of the Study:
- To develop and validate a clinical prediction model for hospitalized COVID-19 patients.
- The model aims to enhance resource management and prognosis determination.
Main Methods:
- Retrospective single-center cohort study of 1,043 COVID-19 patients.
- Analysis included demographic, clinical, laboratory, and radiological data.
- Logistic regression, Cox models, and ROC curve analysis were used for prediction and validation.
Main Results:
- Mortality rate was 23.2%; key predictors included age >80, COPD, low oxygen saturation, multilobar pneumonia, and elevated LDH.
- The derived model showed an AUC of 0.805, and the validation model achieved an AUC of 0.78.
- Common comorbidities were hypertension, dyslipidemia, and diabetes.
Conclusions:
- Advanced age, COPD, low oxygen saturation, multilobar pneumonia, and elevated LDH are significant mortality predictors.
- The validated model effectively stratifies patients into high- and low-risk groups.
- This facilitates improved clinical decision-making and resource management for COVID-19 care.
Objective:
To develop and validate a clinical prediction model aimed at improving resource management and determining the prognosis of patients hospitalized with COVID-19.
Materials And Methods:
A retrospective, single-center cohort study conducted at the University Hospital of Guadalajara, including 1,043 patients hospitalized with COVID-19 between March and May 2020. Data were extracted from hospital records and anonymized. Demographic, clinical, laboratory, radiological, and therapeutic variables were collected, and statistical analysis was performed to identify factors associated with mortality. Logistic regression and Cox models were employed to evaluate mortality predictors. Validation was conducted by comparing ROC curves.
Results:
The median age of the patients was 70.4years (P25-P75: 59-84), with 59.2% being male, and a mortality rate of 23.2%. The most common comorbidities were hypertension (54.8%), dyslipidemia (36.3%), and diabetes (27.1%). Independent predictors of mortality included age over 80years (OR: 6.18), chronic obstructive pulmonary disease (OR: 2.35), oxygen saturation <90% (OR: 1.7), multilobar pneumonia (OR: 2.4), and elevated LDH levels (OR: 1.2). The area under the curve (AUC) for the derivation model was 0.805 (P<.001), and for the validation model, the AUC was 0.78 (P<.001).
Conclusions:
Advanced age, chronic obstructive pulmonary disease, low oxygen saturation, multilobar pneumonia, and elevated LDH levels are significantly associated with increased mortality risk. The validated predictive model enables classification of patients into high- or low-risk groups, thereby facilitating improved clinical decision-making and resource management.
Related Concept Videos
01:21Cancer Survival Analysis
01:15Assumptions of Survival Analysis
01:24Kaplan-Meier Approach
01:13Sensitivity, Specificity, and Predicted Value
Sensitivity is the...